切换至 "中华医学电子期刊资源库"

中华疝和腹壁外科杂志(电子版) ›› 2024, Vol. 18 ›› Issue (06) : 649 -653. doi: 10.3877/cma.j.issn.1674-392X.2024.06.011

论著

A 型肉毒杆菌毒素在腹腔开放后腹壁缺损修复中的应用
王苏睿1, 胡根2, 邵国益1,2,()   
  1. 1.214400 江苏无锡,徐州医科大学江阴临床学院
    2.214400 江苏无锡,南通大学附属江阴医院,江阴市人民医院普外科
  • 收稿日期:2024-10-31 出版日期:2024-12-18
  • 通信作者: 邵国益
  • 基金资助:
    无锡市卫生健康委中青年拔尖人才项目(HB2023102)江阴市中青年卫生优秀人才项目(JYROYT202301)徐州医科大学附属医院发展基金重点项目(XYFZ202302)

Research on the application of botulinum toxin type A in the repair of abdominal wall defects after abdominal opening

Surui Wang1, Gen Hu2, Guoyi Shao1,2,()   

  1. 1.Affiliated Jiangyin Clinical College of Xuzhou Medical University, Jiangyin City, 214400, Jiangsu Province, China
    2.Department of General Surgery, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin 214400, China
  • Received:2024-10-31 Published:2024-12-18
  • Corresponding author: Guoyi Shao
引用本文:

王苏睿, 胡根, 邵国益. A 型肉毒杆菌毒素在腹腔开放后腹壁缺损修复中的应用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 649-653.

Surui Wang, Gen Hu, Guoyi Shao. Research on the application of botulinum toxin type A in the repair of abdominal wall defects after abdominal opening[J/OL]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 649-653.

目的

探究A 型肉毒杆菌毒素(BTA)在腹腔开放后腹壁缺损修复中应用的有效性与安全性。

方法

回顾性分析2018 年7 月至2024 年3 月江阴市人民医院普外科收治的15 例腹腔开放后腹壁缺损患者的临床资料,所有患者均予以注射BTA,并在注射2 周后腹部CT 和超声检查评估腹壁肌肉厚度、长度、密度、腹壁缺损直径及疝囊腹腔容积比等的变化,统计分析治疗前后各项指标变化情况。

结果

与注射前比较,15 例患者注射后2 周左侧腹壁肌肉厚度减少(9.93±6.40)mm,右侧腹壁肌肉厚度减少(9.62±4.73)mm,左侧腹壁肌肉长度增加(24.48±21.66)mm,右侧腹壁肌肉长度增加(18.64±21.60)mm,腹壁缺损直径减少(11.91±10.09)mm,侧腹壁肌肉密度减少(10.67±7.96)HU,疝囊腹腔容积比减少3.61%(6.52%),腹腔内横径增加(9.59±11.60)mm,差异均有统计学意义(P<0.05)。BTA 腹壁注射后对患者排便、排尿功能均无显著影响。

结论

BTA用于腹腔开放后腹壁缺损修复有效且安全。

Objective

To investigate the efficacy and safety of botulinum toxin type A(BTA) in the repair of abdominal wall defects after abdominal opening.

Methods

A retrospective analysis was conducted on the clinical data of 15 patients with abdominal wall defects after open abdominal cavity treated at the Department of General Surgery, Jiangyin People's Hospital, from July 2018 to March 2024.All patients were injected with BTA, and changes in abdominal wall muscle thickness, length, density, defect diameter, and the hernia sac-to-abdominal cavity volume ratio were evaluated 2 weeks after injection.The changes in these parameters before and after treatment were statistically analyzed.

Results

Compared with before injection values, 2 weeks after botulinum toxin injection, the left abdominal wall muscle thickness of 15 patients decreased by (9.93±6.40) mm, and the right abdominal wall muscle thickness decreased by(9.62±4.73) mm.The left abdominal wall muscle length increased by (24.48±21.66) mm, and the right abdominal wall muscle length increased by (18.64±21.60) mm.The abdominal wall defect diameter decreased by (11.91±10.09) mm, the lateral abdominal wall muscle density decreased by (10.67±7.96) HU,and the hernia sac-to-abdominal cavity volume ratio decreased by 3.61% (6.52%).The transverse diameter of the abdominal cavity increased by (9.59±11.60) mm.All differences were statistically significant(P<0.05).Abdominal injection of BTA did not have a significant effect on the patients' bowel or urinary functions.

Conclusion

BTA is effective and safe for the repair of abdominal wall defects after abdominal opening.

图1 腹腔开放后腹壁缺损患者A 型肉毒杆菌毒素注射位点 注:1A 注射点选取部位示意;1B 超声显示各注射点注射肌层。
表1 腹腔开放后腹壁缺损患者A 型肉毒杆菌毒素注射前与注射后2 周观察指标比较(n=15)
表2 有人工肛门的腹腔开放后腹壁缺损患者同期与分期修复注射A 型肉毒杆菌毒素后2 周与注射前观察指标比较(±s
图2 腹部CT 检查腹腔开放后腹壁缺损患者A 型肉毒杆菌毒素注射前后腹壁变化比较 注:2A A 型肉毒杆菌毒素注射前;2B A 型肉毒杆菌毒素注射后。
[1]
Van Ramshorst GH, Eker HH, Hop WC, et al.Impact of incisional hernia on health-related quality of life and body image: a prospective cohort study[J].Am J Surg, 2012, 204(2): 144-150.
[2]
Ibarra-hurtado TR, Nuño-Guzmán CM, Echeagaray-Herrera JE, et al.Use of botulinum toxin type a before abdominal wall hernia reconstruction[J].World J Surg, 2009, 33(12): 2553-2556.
[3]
易昊, 黄兴.两种常用量表在低位直肠癌保肛术后肛门功能评估中的对比[J/OL].世界最新医学信息文摘(连续型电子期刊), 2020,20(50): 106-107.
[4]
Carr WW, Jain N, Sublett JW.Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications[J].Adv Ther, 2021,38(10): 5046-5064.
[5]
Farooque F, Jacombs AS, Roussos E, et al.Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair[J].ANZ J Surg, 2016, 86(1-2): 79-83.
[6]
Bueno-Lledó J, Torregrosa A, Ballester N, et al.Preoperative progressive pneumoperitoneum and botulinum toxin type A in patients with large incisional hernia[J].Hernia, 2017, 21(2): 233-43.
[7]
Wegdam JA, De Vries reilingh TS, Bouvy ND, et al.Prehabilitation of complex ventral hernia patients with Botulinum: a systematic review of the quantifiable effects of Botulinum[J].Hernia, 2021,25(6): 1427-1442.
[8]
Timmer AS, Claessen JJM, Atema JJ, et al.A systematic review and meta-analysis of technical aspects and clinical outcomes of botulinum toxin prior to abdominal wall reconstruction[J].Hernia,2021, 25(6): 1413-1425.
[9]
Claessen JJM, Timmer AS, Hemke R, et al.A computed tomography study investigating the effects of botulinum toxin injections prior to complex abdominal wall reconstruction[J].Hernia, 2023, 27(2): 281-291.
[10]
Tang FX, Zong Z, Xu JB, et al.Combination of Preoperative Progressive Pneumoperitoneum and Botulinum Toxin A Enables the Laparoscopic Transabdominal Preperitoneal Approach for Repairing Giant Inguinoscrotal Hernias[J].J Laparoendosc Adv Surg Tech A,2020, 30(3): 260-266.
[11]
Combination of Preoperative Progressive Pneumoperitoneum and Botulinum Toxin A Enables the Laparoscopic Transabdominal Preperitoneal Approach for Repairing Giant Inguinoscrotal Hernias[J].J Laparoendosc Adv Surg Tech A, 2020, 30(3): 260-266.
[12]
Gu Y, Wang P, Li H, et al.Chinese expert consensus on adult ventral abdominal wall defect repair and reconstruction[J].Am J Surg, 2021,222(1): 86-98.
[13]
Tryliskyy Y, Kebkalo A, Tyselskyi V, et al.Short-term outcomes of minimally invasive techniques in posterior component separation for ventral hernia repair: a systematic review and meta-analysis[J].Hernia, 2024, 28(5): 1497-1509.
[14]
Niu EF, Kozak GM, Mcauliffe PB, et al.Preoperative Botulinum Toxin for Abdominal Wall Reconstruction in Massive Hernia Defects-A Propensity-Matched Analysis[J].Ann Plast Surg, 2023,90(6S Suppl 5): S543-s546.
[15]
Heitmann PT, Vollebregt PF, Knowles CH, et al.Understanding the physiology of human defaecation and disorders of continence and evacuation[J].Nat Rev Gastroenterol Hepatol, 2021, 18(11): 751-769.
[16]
Hill WG.Control of urinary drainage and voiding[J].Clin J Am Soc Nephrol, 2015, 10(3): 480-492.
[17]
Shafik A, El Sibai O, Shafik IA, et al.Electromyographic activity of the anterolateral abdominal wall muscles during rectal filling and evacuation[J].J Surg Res, 2007, 143(2): 364-367.
[18]
Rodriguez-Acevedo O, Elstner KE, Jacombs ASW, et al.Preoperative Botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia[J].Surg Endosc, 2018,32(2): 831-839.
[19]
Elstner KE, Read JW, Saunders J, et al.Selective muscle botulinum toxin A component paralysis in complex ventral hernia repair[J].Hernia, 2020, 24(2): 287-293.
[1] 张涛, 赵胜, 杨小红, 包艳娟, 戢秀勤, 高艳多, 张晓燕. 早孕期胎儿腹壁缺损的超声诊断[J/OL]. 中华医学超声杂志(电子版), 2023, 20(11): 1139-1144.
[2] 董文旭, 童光磊, 李红, 蔡云飞, 王萍. A型肉毒毒素联合悬吊运动训练治疗痉挛型脑性瘫痪患儿的疗效及其对运动功能的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2021, 17(02): 190-197.
[3] 仲卫冬, 胡根, 邵国益. 腹腔开放合并肠空气瘘的管理[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 462-462.
[4] 欧阳阳, 于洋, 熊闻轩, 王辉, 黄榕康. 双面不对称补片在腹壁组织缺损修复中的应用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(02): 125-131.
[5] 师帅, 马文星, 陈昕, 单良, 王泽正, 段降龙, 吴云桦. 腹壁切口疝围手术期并发症发生危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(01): 83-88.
[6] 柯文杰, 王勇. 成人腹壁硬纤维瘤切除术后腹壁组织修复重建的单中心临床研究经验[J/OL]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 535-538.
[7] 赵飞, 董永红. 复合补片联合组织结构分离修复腹壁肿瘤切除后巨大缺损的疗效研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2023, 17(02): 130-136.
[8] 陈德望, 陈树标, 王鉴杰, 谢肖俊. 阔筋膜张肌皮瓣移植在腹壁缺损修复重建的研究进展[J/OL]. 中华疝和腹壁外科杂志(电子版), 2022, 16(04): 385-388.
[9] 金华, 叶静, 王平, 黄永刚. 自体组织瓣在腹壁缺损修复和重建中的应用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2022, 16(04): 378-384.
[10] 杨建军. 肿瘤扩大切除术后复杂腹壁缺损的修复重建[J/OL]. 中华疝和腹壁外科杂志(电子版), 2022, 16(04): 375-377.
[11] 朱云霞, 王锋锋, 徐金美. 优质护理在腹腔镜治疗腹壁缺损患者术后的干预效果分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2021, 15(01): 92-95.
[12] 吴巨钢, 杨建军, 宋致成, 顾岩. 腹壁肿瘤切除术后巨大/超大腹壁缺损的外科修复重建策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2019, 13(06): 500-502.
[13] 王嗣嵩, 任骥, 熊建平, 郑宏伟, 陈昌平, 孙华东, 陈永军, 张桓, 冯文, 潘海鹏. 肉毒杆菌毒素A型治疗慢性偏头痛的疗效分析(附47例报道)[J/OL]. 中华脑科疾病与康复杂志(电子版), 2021, 11(01): 9-13.
[14] 王延召, 牛鹏飞, 丁长民, 高庆坤, 高兆亚, 安柯, 翟志超, 曾庆敏, 黄文生, 雷福明, 顾晋. 结直肠癌致腹壁巨大缺损的一期修补经验(附13例报告)[J/OL]. 中华临床医师杂志(电子版), 2023, 17(05): 557-561.
[15] 汤嘉敏, 梁舒, 钱晶晶. 肉毒杆菌毒素在眼科的应用进展[J/OL]. 中华临床医师杂志(电子版), 2019, 13(12): 952-954.
阅读次数
全文


摘要